Satya Bulusu
Co-founder and Chief Executive Officer @Igy Immunologix
Signup · Get unlimited contacts
WORK HISTORY
Co-founder and Chief Executive Officer @Igy Immunologix
Toronto, ON, CA
Platform Technology Global Life Sciences conglomerate, amalgamation of companies in human health https://zlstherapeutics.com, Nutraceuticals & cosmetics https://zlshealth.com, animal health https://imkuraq.com and Nano Fertilizers plant & soil health https://pomonagri.com. Transitioning from Early Stage to Hyper growth phase.Co-Founder & Group CEO of :I. Biotechnology firm IGY Immunologix https://igylx.com/II. Nutraceuticals & cosmetics Crop & Fertilizers, Animal & Veterinary sciences company https://igylx.com/imkuraq/IV.Zealous Therapeutics Singapore headquartered New Drug Discovery arm led by global Pharma and biotech experienced scientists with a robust pipeline. https://zlstherapeutics.com Innovative Approach:Proprietary technologies for exponential sales growthBioavailability enhancement and targeted delivery solutionsOne Health approach integrating human, animal, plant, and environmental healthPhyquantrix, Orbis immuno, Elvita, Vitonano, Pomona,Biofortus, Phyteon technologies Diverse Product Portfolio:Plant & Soil Health: Nanofertilizers, disease control, crop protection, germination stimulantsAnimal Health: Nanominerals, bio-enhanced, disease control solutionsVeterinary & Human Vaccines with fibroin hydrogel nanoadjuvant tech addressing livestock, poultry diseases and humanHuman Health Nutraceuticals: Addressing lifestyle disorders, deficiencies, chronic conditionsCompetitive Advantages:Wide product range tested and evaluated by scientists, farmers, and customersSustainable solutions aligned with UN Sustainable Development Goals (SDGs)Innovative technologies for enhanced bioavailability and targeted deliveryMoving towards rapid growth with market-validated product solutions.
EDUCATION
Western Sydney University
Master of Business Administration (MBA), International Business
SKILLS
ABOUT SATYA BULUSU
Leading IGY IMMUNOLOGIX into its hyper-growth phase, my focus is on leveraging proprietary technologies to drive exponential sales and enhance bioavailability across our diverse product portfolio. Our approach integrates human https://zlshealth.com animal, https://imkuraq.com and environmental health, reflecting in our innovative One Health solutions.With a tenure that has honed my skills in funding from marquee global PE and IG\'s and global delivery, our team is committed to delivering targeted solutions in new drug discovery, human health, plant and soil health, animal health, and vaccines. As we transition from early-stage to expansive growth, our mission is to sustainably innovate in the health sector.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.